Intrinsiqs

Is ResMed Inc. overvalued?

ResMed Inc. (RMD) looks undervalued — trading about 18% below its fair value.

Undervalued
Current price $226.00 Fair value $266.28
Price
$226.00
Fair value
$266.28
Current P/E
23.8
Normal P/E
28.0
Market cap
$32.78B
Dividend yield
1.1%
Return on equity
23.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RMD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.